Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
195.61B | 218.94B | 263.31B | 184.63B | 119.70B | Gross Profit |
25.06B | 31.25B | 81.64B | 52.46B | 19.95B | EBIT |
25.06B | 31.98B | 45.67B | 27.86B | -4.87B | EBITDA |
41.11B | 50.78B | 59.13B | 37.84B | 8.85B | Net Income Common Stockholders |
15.76B | 21.38B | 20.53B | 16.03B | -7.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
32.76B | 31.62B | 41.77B | 33.66B | 35.90B | Total Assets |
285.49B | 283.65B | 303.86B | 293.46B | 266.13B | Total Debt |
53.56B | 47.87B | 60.77B | 64.55B | 77.30B | Net Debt |
27.71B | 22.41B | 27.74B | 43.20B | 46.03B | Total Liabilities |
165.23B | 164.20B | 189.29B | 178.46B | 160.05B | Stockholders Equity |
117.86B | 116.75B | 111.72B | 111.74B | 103.70B |
Cash Flow | Free Cash Flow | |||
15.95B | 22.96B | 31.68B | 18.07B | 4.04B | Operating Cash Flow |
30.85B | 40.68B | 47.37B | 30.41B | 14.80B | Investing Cash Flow |
-17.40B | -16.45B | -15.12B | -13.66B | -13.08B | Financing Cash Flow |
-14.36B | -29.73B | -19.27B | -26.15B | 1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $115.32B | 11.61 | 16.16% | 3.44% | -2.57% | -14.01% | |
76 Outperform | $277.42B | 16.08 | 11.28% | 4.22% | -1.90% | -14.56% | |
75 Outperform | $128.47B | 9.11 | 13.43% | 4.49% | -10.66% | -23.64% | |
73 Outperform | $485.12B | 13.91 | 14.38% | 3.56% | 1.86% | -11.52% | |
72 Outperform | $44.48B | 19.33 | 8.88% | 1.86% | -4.35% | -37.69% | |
67 Neutral | $42.59B | 13.63 | 16.33% | 2.52% | -6.70% | -57.84% | |
57 Neutral | $8.34B | 5.35 | -5.98% | 7.29% | 0.20% | -69.45% |